JENNIFER FUENTES: Open Payments
NPI 1992906465 · FULLERTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,062 in 31 payments from 19 companies in 2025. Trend: 2023 $880 · 2024 $2,243 · 2025 $3,062
Food & beverage: $3,062
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $375 |
| AstraZeneca Pharmaceuticals LP | 3 | $362 |
| Novo Nordisk Inc | 4 | $275 |
| Lilly USA, LLC | 4 | $218 |
| Axsome Therapeutics, Inc. | 2 | $160 |
| Dexcom, Inc. | 2 | $154 |
| BeOne Medicines USA, Inc. | 1 | $150 |
| Otsuka America Pharmaceutical, Inc. | 1 | $143 |
| Amgen Inc. | 1 | $135 |
| Phathom Pharmaceuticals, Inc. | 1 | $127 |
Products named: Wegovy, AUSTEDO XR, MOUNJARO, Dexcom G6 Transmitter, BRUKINSA, REPATHA, VOQUEZNA, UZEDY.
Industry payments across CA — which companies pay providers there.
